MNTA/NVS/TEVA: Teva Amends Copaxone Suit Against MNTA/NVS: ...and we know that TEVA proposes to amend the suit; we do not know if the 3 additional patents will even come into play. Unless, of course, such amending is normally granted.
"If we don't succeed, we run the risk of failure." -Dan Quayle